BIOSUIS PARVOERY SUSPENSION FOR INJECTION FOR PIGS

For active immunisation of pigs (gilts, sows) to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae and to prevent transplacental infection of embryos and foetuses of gilts and sows caused by porcine parvovirus.

STATEMENT OF ACTIVE AND OTHER SUBSTANCES

Each dose (2 ml) contains:

Active substances:

Parvovirus suis, inactivatum, strain CAPM V198, S-27                       ≥ 4 log₂ ^*)

Erysipelothrix rhusiopathiae, inactivated, serotype 2, strain 2‑64       RP ³ 1 ^**)

*) The titre of HI antibodies in the guinea pig serum after administration of ¼ of the vaccine dose. An antibody titre of 16 and over must be demonstrated in 4 of 5 guinea pigs. The resulting HI titre is determined as the mean of antibody titres achieved in 5 guinea pigs.

**) Relative potency (RP) is determined by comparing the antibody level with the antibody level in the serum prepared with a reference batch of the vaccine that passed the challenge test on target animals according to the Ph.Eur. monograph as amended.
 

Adjuvant:      

Aluminium hydroxide^***)      9.0 mg

***)  hydrated, for adsorption 2% (expressed as Al₂O₃)   

Excipients:     

Formaldehyde                max. 1.0 mg

Thiomersal                              0.2 mg

Suspension for injection.

Milky white to off-white liquid. During prolonged standing, the content is divided into a clear liquid and a milky white to off-white sediment.

INDICATIONS

For active immunisation of pigs (gilts, sows) to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae and to prevent transplacental infection of embryos and foetuses of gilts and sows caused by porcine parvovirus. 

Onset of immunity:

Porcine parvovirus:       3 weeks after basic vaccination (from the beginning of                                    pregnancy)

E. rhusiopathiae:           3 weeks after basic vaccination.

Duration of immunity:

Porcine parvovirus:                 Vaccination provides foetal protection throughout                                            pregnancy.

E. rhusiopathiae:                     6 months after basic vaccination

PACK SIZE:

Paper box: 1 x 10 ml, 1 x 50 ml, 1 x 100 ml, 1 x 250 ml

Plastic box: 10 x 10 ml

Not all pack sizes may be marketed.

 For more information read the package leaflet.